Standout Papers

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-bl... 2016 2026 2019 2022 327
  1. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial (2016)
    Fred Lublin, David H. Miller et al. The Lancet

Immediate Impact

5 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Lifetime risk and projected burden of dementia
2025 Standout
Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
2024 Standout
2 intermediate papers

Works of Fonda Liu being referenced

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
2019
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
2016 Standout

Author Peers

Author Last Decade Papers Cites
Fonda Liu 80 119 35 268 112 8 442
G. S. M. Ramsaransing 31 90 11 359 137 13 485
Wildéa Lice de Carvalho Jennings Pereira 27 67 7 251 85 11 375
Jonathan L. Carter 26 97 46 264 114 12 456
M. Rieks 28 111 9 140 47 9 446
Tinka Tuinstra 57 193 11 83 59 9 380
E. Redford 104 82 15 187 208 7 474
Carmen Picón 85 163 9 189 71 15 495
Silvana Montella 35 59 35 125 79 12 395
Carolina Cruciani 49 142 4 278 93 10 503
A. Warren 50 141 19 66 51 9 508

All Works

Loading papers...

Rankless by CCL
2026